HL Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

HL Financial Services’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$276K	Sell	3,400 -500	-13%	-$32.3K	﹤0.01%	636
2018 Q4	$211K	Hold	3,900	–	–	﹤0.01%	680
2018 Q3	$201K	Sell	3,900 -5,100	-57%	-$240K	﹤0.01%	726
2018 Q2	$375K	Buy	9,000 +2,800	+45%	+$124K	0.01%	539
2018 Q1	$273K	Buy	6,200 +637	+11%	+$32.4K	﹤0.01%	605
2017 Q4	$280K	Buy	5,563 +63	+1%	+$3.46K	0.01%	522
2017 Q3	$279K	Hold	5,500	–	–	0.01%	590
2017 Q2	$280K	Sell	5,500 -1,000	-15%	-$46.6K	0.01%	598
2017 Q1	$261K	Hold	6,500	–	–	0.01%	593
2016 Q4	$311K	Buy	6,500 +600	+10%	+$23.7K	0.01%	546
2016 Q3	$216K	Buy	+5,900	New	+$185K	0.01%	607
2016 Q2	–	Sell	-5,900	Closed	-$239K	–	670
2016 Q1	$239K	Hold	5,900	–	–	0.01%	574
2015 Q4	$365K	Hold	5,900	–	–	0.01%	508
2015 Q3	$238K	Buy	5,900 +500	+9%	+$25.9K	0.01%	557
2015 Q2	$311K	Hold	5,400	–	–	0.01%	557
2015 Q1	$344K	Hold	5,400	–	–	0.01%	537
2014 Q4	$333K	Buy	+5,400	New	+$266K	0.01%	527

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HL Financial Services's IONS Position: Q1 2019 in Review

HL Financial Services reduced its Ionis Pharmaceuticals (IONS) stake by 13% in Q1 2019, selling an estimated $32.3K and leaving 3,400 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

HL Financial Services first reported a position in IONS in Q4 2014 and has held it in 17 quarters since. The position peaked at $375K in Q2 2018. 392 funds tracked by Wall St. Rank hold IONS as of Q1 2019.

HL Financial Services held 3,400 shares of Ionis Pharmaceuticals worth $276K as of Q1 2019.
HL Financial Services sold 500 Ionis Pharmaceuticals shares in Q1 2019, an estimated $32.3K.
Ionis Pharmaceuticals made up ﹤0.01% of HL Financial Services's portfolio in Q1 2019, its #636 holding.
HL Financial Services first reported a position in Ionis Pharmaceuticals in Q4 2014 and has held it in 17 quarters since.
HL Financial Services's Ionis Pharmaceuticals position peaked at $375K in Q2 2018.
392 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.